2-Methyl-DMT

2-Methyl-DMT
Clinical data
Other names2-Me-DMT; 2-Methyl-N,N-dimethyltryptamine; 2,N,N-Trimethyltryptamine; 2,N,N-TMT; 2-TMT; Desmethoxy-Indapex; 3-[2-(Dimethylamino)ethyl]-2-methylindole;
Routes of
administration
Oral
ATC code
  • None
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
Pharmacokinetic data
Duration of action4–6 hours
Identifiers
  • (2-(2-methyl-1H-indol-3-yl)-1-methyl-ethyl)dimethylamine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H18N2
Molar mass202.301 g·mol−1
3D model (JSmol)
  • Cc1c(c2ccccc2[nH]1)CCN(C)C
  • InChI=1S/C13H18N2/c1-10-11(8-9-15(2)3)12-6-4-5-7-13(12)14-10/h4-7,14H,8-9H2,1-3H3
  • Key:NDGCOWDSLVNLGE-UHFFFAOYSA-N
  (verify)

2-Methyl-DMT, or 2-Me-DMT, also known as 2-methyl-N,N-dimethyltryptamine or as 2,N,N-trimethyltryptamine (2,N,N-TMT or 2-TMT), is a psychoactive drug of the tryptamine family related to the psychedelic drug dimethyltryptamine (DMT). It is not a conventional psychedelic, but instead produces tactile enhancement and auditory distortion. The drug was described by Alexander Shulgin and reported in his book TiHKAL (Tryptamines I Have Known and Loved).